• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肌炎患者间质性肺炎的趋化因子谱:病例对照研究。

Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.

机构信息

Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka, Japan.

Department of Mathematics, Osaka Medical College, Takatsuki, Osaka, Japan.

出版信息

Sci Rep. 2017 May 9;7(1):1635. doi: 10.1038/s41598-017-01685-5.

DOI:10.1038/s41598-017-01685-5
PMID:28487565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5431618/
Abstract

Chemokines play an important role in the pathophysiology of dermatomyositis (DM) with interstitial pneumonia (IP). However, the relation between chemokines and the disease activity or prognosis of DM-IP has not been elucidated. We evaluated the serum C-C motif chemokine ligand (CCL) 2, Th1 chemokines (C-X-C motif chemokine ligand [CXCL] 9, CXCL10, CXCL11), and Th2 chemokine (CCL17) profiles of 30 patients, and examined the relation between these chemokines and the disease activity or prognosis of DM-IP. Initial serum CCL2 level was higher in the death group (P = 0.007). To determine the cut-off points effective as poor prognostic factors of DM-IP, ROC curve analysis was carried out on initial serum CCL2 level. The value that maximized the area under the ROC curve was 894 pg/mL (sensitivity: 100%, specificity: 70.8%). Serum CCL2, CXCL9, CXCL10, and CXCL11 levels were lower at 2 weeks after treatment initiation than before treatment. Serum CCL2, CXCL10, and CXCL11 levels at 2 weeks after treatment initiation were higher in the death group. Serum levels of chemokines such as CCL2, CXCL10, and CXCL11 may be possible biomarkers of disease activity and prognosis in DM-IP, and serum CCL2 level may be useful when deciding initial treatment.

摘要

趋化因子在皮肌炎(DM)伴间质性肺炎(IP)的病理生理学中起着重要作用。然而,趋化因子与 DM-IP 的疾病活动或预后之间的关系尚未阐明。我们评估了 30 例患者的血清 C-C 基序趋化因子配体(CCL)2、Th1 趋化因子(C-X-C 基序趋化因子配体[CXCL]9、CXCL10、CXCL11)和 Th2 趋化因子(CCL17)谱,并检查了这些趋化因子与 DM-IP 的疾病活动或预后之间的关系。死亡组初始血清 CCL2 水平较高(P=0.007)。为了确定作为 DM-IP 不良预后因素的有效截止值,对初始血清 CCL2 水平进行了 ROC 曲线分析。ROC 曲线下面积最大化的数值为 894 pg/mL(敏感性:100%,特异性:70.8%)。治疗开始后 2 周,血清 CCL2、CXCL9、CXCL10 和 CXCL11 水平低于治疗前。治疗开始后 2 周,死亡组血清 CCL2、CXCL10 和 CXCL11 水平较高。CCL2、CXCL10 和 CXCL11 等趋化因子的血清水平可能是 DM-IP 疾病活动和预后的潜在生物标志物,在决定初始治疗时,血清 CCL2 水平可能有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/03f326cff32a/41598_2017_1685_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/5fb430a2931b/41598_2017_1685_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/a2dbab5b9036/41598_2017_1685_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/03f326cff32a/41598_2017_1685_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/5fb430a2931b/41598_2017_1685_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/a2dbab5b9036/41598_2017_1685_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a1/5431618/03f326cff32a/41598_2017_1685_Fig3_HTML.jpg

相似文献

1
Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.皮肌炎患者间质性肺炎的趋化因子谱:病例对照研究。
Sci Rep. 2017 May 9;7(1):1635. doi: 10.1038/s41598-017-01685-5.
2
Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study.血清LIGHT水平升高与皮肌炎患者间质性肺炎的疾病进展和严重程度相关:一项病例对照研究。
PLoS One. 2015 Oct 8;10(10):e0140117. doi: 10.1371/journal.pone.0140117. eCollection 2015.
3
Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study.血清富含亮氨酸α-2 糖蛋白水平升高与皮肌炎患者间质性肺炎的疾病预后、进展和活动的相关性:一项回顾性研究。
PLoS One. 2020 Jun 1;15(6):e0234090. doi: 10.1371/journal.pone.0234090. eCollection 2020.
4
Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis.治疗后第 4 周内血清 KL-6 和表面活性蛋白 D 水平显著升高预示着与皮肌炎/多发性肌炎相关的活动性间质性肺炎患者预后不良。
Mod Rheumatol. 2013 Sep;23(5):872-83. doi: 10.1007/s10165-012-0756-0. Epub 2012 Sep 17.
5
Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients.抗MDA5抗体阳性皮肌炎患者间质性肺炎临床预后因素的评估
Mod Rheumatol. 2018 Jan;28(1):133-140. doi: 10.1080/14397595.2017.1318468. Epub 2017 May 11.
6
Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis.细胞因子和趋化因子的测定及其与皮肌炎和无肌病性皮肌炎临床严重程度的相关性。
Br J Dermatol. 2018 Dec;179(6):1334-1341. doi: 10.1111/bjd.17079. Epub 2018 Oct 7.
7
Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].治疗前铁蛋白水平和肺泡-动脉氧分压差可预测环孢素A/糖皮质激素联合治疗的皮肌炎急性/亚急性间质性肺炎死亡率:一项病例对照研究[校正后]
PLoS One. 2014 Feb 21;9(2):e89610. doi: 10.1371/journal.pone.0089610. eCollection 2014.
8
Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.白细胞介素-6、I型干扰素调节基因和趋化因子可标志皮肌炎的疾病活动度。
Arthritis Rheum. 2009 Nov;60(11):3436-46. doi: 10.1002/art.24936.
9
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.抗黑色素瘤分化相关基因5抗体低阳性滴度与皮肌炎患者间质性肺病的长期不良预后无关。
Respir Investig. 2018 Nov;56(6):464-472. doi: 10.1016/j.resinv.2018.07.007. Epub 2018 Aug 24.
10
Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.与青少年皮肌炎相关的致命性快速进展性间质性肺疾病的临床和实验室特征
Rheumatology (Oxford). 2015 May;54(5):784-91. doi: 10.1093/rheumatology/keu385. Epub 2014 Oct 6.

引用本文的文献

1
CA 15 - 3 in screening for systemic autoimmune rheumatic disease associated interstitial lung disease: a single center cross-sectional study.CA 15-3 在系统性自身免疫性风湿病相关间质性肺病筛查中的应用:一项单中心横断面研究。
Rheumatol Int. 2024 Oct;44(10):2017-2025. doi: 10.1007/s00296-024-05694-2. Epub 2024 Aug 24.
2
CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.CXCL9 可能作为原发性干燥综合征伴外分泌腺表现的潜在生物标志物。
Arthritis Res Ther. 2024 Jan 17;26(1):26. doi: 10.1186/s13075-023-03229-x.
3
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.

本文引用的文献

1
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.多发性肌炎/皮肌炎相关间质性肺疾病中肌炎特异性自身抗体的综合评估
Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2.
2
Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis.初始有限的三级薄层计算机断层扫描评分可预测皮肌炎患者急性/亚急性间质性肺炎的预后。
Mod Rheumatol. 2016 Sep;26(5):738-43. doi: 10.3109/14397595.2015.1134392. Epub 2016 Jun 2.
3
结缔组织病相关间质性肺疾病的临床相关生物标志物。
Immunol Allergy Clin North Am. 2023 May;43(2):411-433. doi: 10.1016/j.iac.2023.01.012. Epub 2023 Mar 3.
4
Comparison of cytokine/chemokine profiles between dermatomyositis and anti-synthetase syndrome.皮肌炎与抗合成酶综合征细胞因子/趋化因子谱的比较。
Front Neurol. 2022 Dec 8;13:1042580. doi: 10.3389/fneur.2022.1042580. eCollection 2022.
5
Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice.急性肺损伤中肺细胞的病理作用:来自临床实践的教训。
Int J Mol Sci. 2022 Nov 30;23(23):15027. doi: 10.3390/ijms232315027.
6
Autophagy-related genes are potential diagnostic biomarkers for dermatomyositis.自噬相关基因是皮肌炎潜在的诊断生物标志物。
Ann Transl Med. 2022 Feb;10(4):228. doi: 10.21037/atm-22-70.
7
Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features-What Do We Already Know?综述:自身免疫特征性间质性肺炎中肺纤维化的血清生物标志物——我们已经了解了什么?
J Clin Med. 2021 Dec 24;11(1):79. doi: 10.3390/jcm11010079.
8
Transcriptome Sequencing Identifies as an Important Player in Patients With Dermatomyositis-Associated Interstitial Lung Disease.转录组测序确定 为皮肌炎相关间质性肺疾病患者的重要参与者。 (原文此处有缺失信息)
Front Genet. 2021 Dec 6;12:784215. doi: 10.3389/fgene.2021.784215. eCollection 2021.
9
Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.进行性纤维化间质性肺疾病中的生物标志物:优化诊断、预后及治疗反应
Front Med (Lausanne). 2021 May 10;8:680997. doi: 10.3389/fmed.2021.680997. eCollection 2021.
10
CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.CXCL9、CXCL10 和 CXCL11;与胶原血管疾病相关的间质性肺疾病和具有自身免疫特征的间质性肺炎患者自身免疫相关肺部炎症的生物标志物。
PLoS One. 2020 Nov 2;15(11):e0241719. doi: 10.1371/journal.pone.0241719. eCollection 2020.
Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
合并快速进展性或慢性间质性肺疾病的多发性肌炎和皮肌炎中的细胞因子谱。
Rheumatology (Oxford). 2014 Dec;53(12):2196-203. doi: 10.1093/rheumatology/keu258. Epub 2014 Jun 26.
4
IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis.白细胞介素-6、白细胞介素-8 和白细胞介素-10 与伴有肌炎/皮肌炎的快速进展性间质性肺病的高铁蛋白血症相关。
Biomed Res Int. 2014;2014:815245. doi: 10.1155/2014/815245. Epub 2014 Apr 1.
5
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis.血清干扰素-α是抗黑色素瘤分化相关基因5(MDA5)抗体阳性皮肌炎患者的一种有用生物标志物。
Mod Rheumatol. 2015 Jan;25(1):85-9. doi: 10.3109/14397595.2014.900843. Epub 2014 Apr 9.
6
Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].治疗前铁蛋白水平和肺泡-动脉氧分压差可预测环孢素A/糖皮质激素联合治疗的皮肌炎急性/亚急性间质性肺炎死亡率:一项病例对照研究[校正后]
PLoS One. 2014 Feb 21;9(2):e89610. doi: 10.1371/journal.pone.0089610. eCollection 2014.
7
Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis.环孢素 A 联合皮质类固醇治疗皮肌炎相关急性间质性肺炎的疗效。
Mod Rheumatol. 2003 Sep;13(3):231-8. doi: 10.3109/s10165-003-0205-1.
8
Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease.血清白细胞介素6水平作为快速进展性间质性肺病的临床无肌病性皮肌炎的有用预后预测指标。
Mod Rheumatol. 2014 Jul;24(4):633-6. doi: 10.3109/14397595.2013.844390. Epub 2013 Nov 4.
9
Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.抗 MDA5 抗体、铁蛋白和 IL-18 单点评估预测抗 MDA5 抗体阳性皮肌炎间质性肺病预后的局限性。
Clin Rheumatol. 2013 Mar;32(3):395-8. doi: 10.1007/s10067-012-2142-x. Epub 2012 Dec 19.
10
Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.I 型干扰素系统在成人发病的临床无肌病性皮肌炎中的失调可能对间质性肺病的发展有一定的贡献。
Br J Dermatol. 2012 Dec;167(6):1236-44. doi: 10.1111/j.1365-2133.2012.11145.x. Epub 2012 Sep 27.